gold nanorods + anti-EGFR antibody

**Gold nanorods + anti-EGFR antibody** is a preclinical EGFR-targeted nanomedicine platform composed of plasmonic gold nanorods conjugated to antibodies against epidermal growth factor receptor. The construct is intended for selective cancer cell binding, imaging, and near-infrared photothermal ablation rather than conventional receptor-blocking pharmacology. After binding EGFR-overexpressing tumor cells, external near-infrared laser exposure heats the gold nanorods through plasmon resonance and induces localized tumor cell death, including apoptosis, with published work focusing especially on bladder cancer and other EGFR-overexpressing squamous malignancies. Based on the provided context, this appears to be an academic research platform rather than a named clinical drug product, with no specific company-sponsored clinical candidate, brand, or commercial manufacturer clearly identified.

Other names

gold nanorods conjugated with anti-EGFR antibodyAuNRs functionalized with anti-EGFR antibodyEGFR-targeted gold nanorodsanti-EGFR antibody-conjugated gold nanorods